This ability to distinguish between similar disease groups with high accuracy makes LCN2 an attractive biomarker for CM, which is commonly misdiagnosed as similarly presenting diseases including intracranial haemorrhage, Reye’s syndrome, poisoning and rabies (Beare et al., 2011). The gene discussed is LCN2; the disease is cutaneous mastocytosis.